Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Published
Recomendaciones sobre el tratamiento y monitoreo de personas con cáncer durante la pandemia de COVID-19
Recommendations on the treatment and monitoring of patients with cancer during the COVID-19 pandemic
Recomendações sobre o tratamento e monitoramento de pessoas com câncer durante a pandemia da covid-19
DOI:
https://doi.org/10.15446/av.enferm.v38n1supl.88868Keywords:
Coronavirus, Neoplasias, Atención al Paciente, Pandemias (es)Coronavirus, Neoplasms, Patient Care, Pandemics (en)
Coronavirus, Neoplasias, Assistência ao Paciente, Pandemias (pt)
Downloads
Objetivo: presentar la evidencia disponible sobre el tratamiento y monitoreo de personas con cáncer durante la pandemia de COVID-19.
Síntesis de contenido: revisión exploratoria de alcance en las bases de datos Academic Search Complete, Biblioteca Virtual en Salud, Elsevier, Google Scholar, PubMed y Science Direct, en idiomas inglés y español, a través de ecuaciones de búsqueda preestablecidas. Los hallazgos se organizaron en siete categorías: relación entre COVID-19 y cáncer; población oncológica en mayor riesgo; cuidado de pacientes oncológicos con COVID-19; continuidad del tratamiento antineoplásico; investigación en cáncer; profesionales de la salud; e impacto de la pandemia en el manejo del cáncer. Se resalta que el contagio del virus SARS-CoV-2 podría aumentar el riesgo de morbilidad y mortalidad en este tipo de pacientes, por lo que ha de priorizarse el tratamiento de COVID-19 frente al tratamiento antineoplásico.
Conclusiones: resulta necesario buscar alternativas para darle continuidad al tratamiento de cáncer del resto de la población oncológica. De otra parte, debe propenderse por el bienestar físico y mental del talento humano en salud y por la mitigación del impacto económico y sanitario de la pandemia.
Objective: To present available evidence on the treatment and monitoring of people with cancer during the COVID-19 pandemic.
Content synthesis: An exploratory search in English and Spanish was made in the databases Academic Search Complete, Biblioteca Virtual en Salud, Elsevier, Google Scholar, PubMed and Science Direct using
pre-established search equations. Results were organized into 7 categories: relationship between COVID-19 and cancer; cancer population at highest risk; care of cancer patients with COVID-19; continuity of cancer treatment; cancer research; health professionals; and impact of the pandemic on cancer management. The contagion of SARS-CoV-2 could lead to an increased risk of morbidity and mortality in cancer patients. Therefore, COVID-19 treatment should be prioritized over the antineoplastic treatment.
Conclusions: It is necessary to explore alternatives to continue cancer treatment in the rest of the population with cancer. We must also improve the physical and mental wellbeing of healthcare workers and mitigate the impact of this pandemic on economic and healthcare systems.
Objetivo: apresentar as evidências disponíveis sobre o tratamento e monitoramento de pessoas com câncer durante a pandemia do novo coronavírus (covid-19).
Síntese de conteúdo: revisão de literatura com busca nas bases de dados Academic Search Complete, Biblioteca Virtual em Saúde, Elsevier, Google Scholar, PubMed e Science Direct, em inglês e espanhol, mediante pesquisas preestabelecidas. Os
resultados foram organizados em sete categorias: relação entre covid-19 e câncer; população de câncer de maior risco; atendimento a pacientes com câncer com covid-19; continuidade do tratamento antineoplásico; pesquisa sobre câncer; profissionais de saúde, e impacto da pandemia no tratamento do câncer. Destaca-se que a disseminação do vírus Sars-CoV-2 pode aumentar o risco de morbimortalidade em pacientes com câncer, portanto o tratamento da covid-19 deve ser priorizado em relação ao tratamento antineoplásico.
Conclusões: devem-se procurar alternativas para continuar o tratamento do câncer no restante da população oncológica. Por sua vez, deve-se propender para a saúde física e mental do talento humano em saúde e para mitigar o impacto da pandemia na saúde e na economia.
References
(1) Sánchez VG; Laza VC; Estupiñán GC; Estupiñán GL. Barreras de acceso a los servicios de salud: narrativas de mujeres con cáncer de mama en Colombia. Rev. Fac. Nac. Salud Pública. 2014;32(3):305-313. https://bit.ly/2GLUiBu
(2) Hanna TP; Evans GA; Booth CM. Cancer, COVID-19 and the precautionary principle: Prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17:268-270. https://doi.org/10.1038/s41571-020-0362-6
(3) Organización Mundial de la Salud. Novel Coronavirus (2019-nCoV). Situation Report I; 2020. https://bit.ly/314nAlv
(4) Organización Mundial de la Salud. WHO Timeline - COVID-19; 2020. https://bit.ly/34QOBu0
(5) Sidaway P. COVID-19 and cancer: What we know so far. Nat Rev Clin Oncol. 2020;17(336):386-388. https://doi.org/10.1038/s41571-020-0366-2
(6) American Cancer Society. Infecciones en personas con cáncer; 2020. https://bit.ly/3nL31Ez
(7) American Cancer Society. Preguntas comunes acerca del brote de COVID-19. Noticias. 2020. https://bit.ly/33T6sRt
(8) Organización Mundial de la Salud. El diagnóstico temprano del cáncer salva vidas y reduce los costos de tratamiento; 2017. https://bit.ly/3nLGirL
(9) National Cancer Institute. Coronavirus: What People with Cancer Should Know; 2020. https://bit.ly/33UJdqv
(10) Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JPA et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. https://doi.org/10.1136/bmj.b2700
(11) Liang W; Guan W; Chen R; Wang W; Li J; Xu K et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337. https://doi.org/10.1016/S1470-2045(20)30096-6
(12) Ganatra S; Hammond S; Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC Cardio Oncology. 2020;2(2):350-355. http://doi.org/10.1016/j.jaccao.2020.03.001
(13) Curigliano G. How to guarantee the best of care to patients with cancer during the COVID-19 epidemic: The italian experience. Oncologist. 2020;25(6):463-467. http://doi.org/10.1634/theoncologist.2020-0267
(14) Shankar A; Saini D; Roy S; Jarrahi AM; Chakraborty A; Bharati SJ; Taghizadeh-Hesary F. Cancer care delivery challenges amidst coronavirus disease 19 (COVID-19) outbreak: Specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pacific J Cancer Prev. 2020;21(3):569-573. http://doi.org/10.31557/APJCP.2020.21.3.569
(15) Zhang L; Zhu F; Xie L; Wang C; Wang J; Chen R et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. http://doi.org/10.1016/j.annonc.2020.03.296
(16) Pothuri B; Secord AA; Armstrong DK; Chan J; Fader AN; Huh W et al. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis. Gynecol Oncol. 2020;158(1):16-24. https://doi.org/10.1016/j.ygyno.2020.04.694
(17) Chen Y; Li G. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak. Gynecol Oncol. 2020;158(1):44-46. http://doi.org/10.1016/j.ygyno.2020.04.709
(18) Ouyang W; Yu J; Zhang J; Xie C. Alert to potential contagiousness: A case of lung cancer with asymptomatic SARS-CoV-2 infection. J Thorac Oncol. 2020;15(6):e82-83. https://doi.org/10.1016/j.jtho.2020.04.005
(19) McGinnis GJ; Ning MS; Nitsch PL; O’Reilly M; McAleer MF; Koong AC; Chanj JY. Rapid detection of asymptomatic coronavirus disease 2019 by computed tomography image guidance for stereotactic ablative radiotherapy. J Thorac Oncol. 2020;15(6):1085-1087. http://doi.org/10.1016/j.jtho.2020.04.007
(20) Cortiulia F; Pettke A; Bartoletti M; Puglisi F; Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020;31(5):553-555. https://doi.org/10.1016/j.annonc.2020.03.286
(21) Paterson C; Gobel B; Gosselin T; Haylock PJ; Papadopoulou C; Slusser K et al. Oncology nursing during a pandemic: critical reflections in the context of COVID-19. Semin Oncol Nurs. 2020;36(3):151028. https://doi.org/10.1016/j.soncn.2020.151028
(22) Public Health England. Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. Coronavirus (COVID-19) Guidance and support. 2020. https://bit.ly/34QUzLn
(23) Kattan J; Kattan C; Assi T. Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? Immunotherapy. 2020;12(6):32290754. http://doi.org/10.2217/imt-2020-0077
(24) Ardura M; Hartley D; Dandoy C; Lehmann L; Jaglowski S; Auletta JJ. Addressing the impact of the Coronavirus Disease (COVID-19) pandemic on hematopoietic cell transplantation: Learning networks as means for sharing best practices. Biol Blood Marrow Transplant. 2020;26(7):E147-160. https://doi.org/10.1016/j.bbmt.2020.04.018
(25) Falandry C; Filteau C; Ravot C; Le Saux O. Challenges with the management of older patients with cancer during the COVID-19 pandemic. J Geriatr Oncol. 2020;11(5):747-749. https://doi.org/10.1016/j.jgo.2020.03.020
(26) Mohile S; Dumontier C; Mian H; Loh KP; Williams GR; Wildes TM et al. Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States. J Geriatr Oncol. 2020;11(5):753-760. https://doi.org/10.1016/j.jgo.2020.04.010
(27) Wang H; Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):E181. https://doi.org/10.1016/S1470-2045(20)30149-2
(28) Passaro A; Peters S; Mok T; Attili I; Mitsudomi T; de Marinis F. Testing for COVID-19 in lung cancer patients. Ann Oncol. 2020;31(7):832-834. http://doi.org/10.1016/j.annonc.2020.04.002
(29) Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020;12(5):269-273. http://doi.org/10.2217/imt-2020-0067
(30) Zhao Z; Bai H; Duan J; Wang J. Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic. Thorac Cancer. 2020;11(6):1752-1757. http://doi.org/10.1111/1759-7714.13424
(31) Rubinstein SM; Steinharter JA; Warner J; Rini BI; Peters S; Choueiri TK. The COVID-19 and cancer consortium (CCC19): A collaborative effort to understand the effects of COVID-19 on patients with cancer. Cell Press. 2020;37(6):738-741. http://doi.org/10.1016/j.ccell.2020.04.018
(32) Day AT; Sher DJ; Lee RC; Truelson JM; Myers LL; Sumer BD et al. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105:104684. https://doi.org/10.1016/j.oraloncology.2020.104684
(33) Mian H; Grant SJ; Engelhardt M; Pawlyn C; Bringhen S; Zweegman S et al. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. J Geriatr Oncol. 2020;11(5):764-768. http://doi.org/10.1016/j.jgo.2020.04.008
(34) Scotté F; Minvielle E; Mir O; André F; Barlesi F; Soria J-C. A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19 positive patients with cancer. Eur J Cancer. 2020;132:1-4. http://doi.org/10.1016/j.ejca.2020.03.020
(35) Rivera A; Ohri N; Thomas E; Miller R; Knoll MA. The impact of COVID-19 on radiation oncology clinics and patients with cancer in the United States. Adv Radiat Oncol. 2020;5(4):538-543. https://doi.org/10.1016/j.adro.2020.03.006
(36) Tey J; Ho S; Choo BA; Ho F; Yap SP; Tuan JKL et al. Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in singapore. Radiother Oncol. 2020;148:189-93. https://doi.org/10.1016/j.radonc.2020.03.030
(37) Gregucci F; Caliandro M; Surgo A; Carbonara R; Bonaparte I; Fiorentino A. Cancer patients in Covid-19 era: Swimming against the tide. Radiother Oncol. 2020;149:109-110. http://doi.org/10.1016/j.radonc.2020.04.002
(38) Combs SE; Belka C; Niyazi M; Corradini S; Pigorsch S; Wilkens J et al. First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Radiat Oncol. 2020;15:74. https://doi.org/10.1186/s13014-020-01527-1
(39) Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international collaborative group. Oncologist. 2020;25(6):e936-945. http://doi.org/10.1634/theoncologist.2020-0213
(40) Wei W; Zheng D; Lei Y; Wu S; Verma V; Liu Y et al. Radiotherapy workflow and protection procedures during the coronavirus disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China. Radiother Oncol. 2020;148:203-210. https://doi.org/10.1016/j.radonc.2020.03.029
(41) Wu S; Zheng D; Liu Y; Hu D; Wei W; Han G. Radiation therapy care during a major outbreak of COVID-19 in Wuhan. Adv Radiat Oncol. 2020;5(4):531-533. https://doi.org/10.1016/j.adro.2020.03.004
(42) Alhalabi O; Subbiah V. Managing cancer care during the COVID-19 pandemic and beyond. Trends Cancer. 2020;6(7):533-535. https://doi.org/10.1016/j.trecan.2020.04.005
(43) Oncology Nursing Society. COVID-19 fact sheet and implications for patients with cancer. ONS VOICE. 2020. https://bit.ly/31k2XCf
(44) Zhang L; Zheng Z; Hu G; Yuan X. Prevention and control measure to avoid cross infection during radiotherapy in coronavirus disease 2019 (COVID-19) epidemic in Wuhan, China. Radiother Oncol. 2020;149:104-106. http://doi.org/10.1016/j.radonc.2020.04.011
(45) Coles CE; Aristei C; Bliss J; Boersma L; Brunt AM; Chatterjee S et al. International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol. 2020;32(5):279-281. https://doi.org/10.1016/j.clon.2020.03.006
(46) Kumar J; Raina R. Recommendations for surgery during the COVID-19 pandemic. Indian J Surg. 2020;82(2):124-128. https://doi.org/10.1007/s12262-020-02467-6
(47) Tchelebi LT; Haustermans K; Scorsetti M; Hosni A; Huguet F; Hawkins MA et al. Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19. Radiother Oncol. 2020;148:194-200. https://doi.org/10.1016/j.radonc.2020.04.010
(48) Kumar S; Chmura S; Robinson C; Lin SH; Gadgeel SM; Donington J et al. Alternative multidisciplinary management options for locally advanced non-small cell lung cancer during the COVID-19 global pandemic. J Thorac Oncol. 2020;15(7):1137-1146. https://doi.org/10.1016/j.jtho.2020.04.016
(49) Patel K; Choudhury A; Hoskin P; Varughese M; James N; Huddart R; Birtle A. Clinical guidance for the management of patients with urothelial cancers during the COVID-19 pandemic - Rapid review. Clin Oncol. 2020;32(6):347-353. http://doi.org/10.1016/j.clon.2020.04.005
(50) Rodler S; Apfelbeck M; Stief C; Heinemann V; Casuscelli J. Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany? Eur J Cancer. 2020;132:136-140. https://doi.org/10.1016/j.ejca.2020.04.003
(51) Lalani A-KA; Chi KN; Heng DYC; Kollmannsberger CK; Sridhar SS; Blais N et al. Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Can Urol Assoc J. 2020;14(5):E154-158. https://doi.org/10.5489/cuaj.6595
(52) ASTRO. COVID-19 FAQS; 2020. https://bit.ly/3dldemk
(53) Thomson DJ; Palma D; Guckenberger M; Balermpas P; Beitler JJ; Blanchard P et al. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Int J Radiat Oncol. 2020;107(4):618-627. https://doi.org/10.1016/j.ijrobp.2020.04.016
(54) Williams VM; Kahn JM; Harkenrider MM; Chino J; Chen J; Fang LC et al. COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation. Brachytherapy. 2020;19(4):401-411. https://doi.org/10.1016/j.brachy.2020.04.005
(55) De Felice F; Polimeni A; Tombolini V. The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care. Radiother Oncol. 2020;147:84-85. http://doi.org/10.1016/j.radonc.2020.03.020
(56) Soran A; Gimbel M; Diego E. Breast cancer diagnosis, treatment and follow-up during COVID-19 pandemic. Eur J Breast Heal. 2020;16(2):86-88. http://doi.org/10.5152/ejbh.2020.240320
(57) Çakmak GK; Özmen V. Sars-CoV-2 (COVID-19) outbreak and breast cancer surgery in Turkey. Eur J Breast Health. 2020;16(2):83-85. http://doi.org/10.5152/ejbh.2020.300320
(58) Monk BJ; Coleman RL; Moore KN; Herzog TJ; Secord AA; Matulonis UA et al. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020;158(1):34-36. https://doi.org/10.1016/j.ygyno.2020.04.703
(59) Bachanova V; Bishop MR; Dahi P; Dholaria B; Grupp SA; Hayes-Lattin B et al. Chimeric antigen receptor T cell therapy during the COVID-19 pandemic. Biol Blood Marrow Transplant. 2020;26(7):1239-1246. https://doi.org/10.1016/j.bbmt.2020.04.008
(60) Thoracic Surgery Outcomes Research Network. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. Ann Thorac Surg. 2020;110(2):692-696. https://doi.org/10.1016/j.athoracsur.2020.03.005
(61) COVID-19 Subcommittee of the O.R. Executive Committee at Memorial Sloan Kettering. Cancer surgery and COVID-19. Ann Surg Oncol. 2020;27(6):1713-1716. https://doi.org/10.1245/s10434-020-08462-1
(62) Glehen O; Kepenekian V; Bouché O; Gladieff L; Honore C. Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups. J Visc Surg. 2020;157(3S1):S25-31. http://doi.org/10.1016/j.jviscsurg.2020.04.013
(63) Moujaess E; Kourie HR; Ghosn M. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Crit Rev Oncol Hematol. 2020;150:102972. http://doi.org/10.1016/j.critrevonc.2020.102972
(64) Interventional Oncology Branch of China Anti-Cancer Association; Lyu T; Song L; Jin L; Zou Y. Expert consensus on the procedure of interventional diagnosis and treatment of cancer patients during the COVID-19 epidemic. J Interv Med. 2020;3(2):61-64. https://doi.org/10.1016/j.jimed.2020.03.001
(65) Marijnen CAM; Peters FP; Rödel C; Bujko K; Haustermans K; Fokas E et al. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID-19 pandemic. Radiother Oncol. 2020;148:213-215. https://doi.org/10.1016/j.radonc.2020.03.039
(66) Dietz JR; Moran MS; Isakoff SJ; Kurtzman SH; Willey SC; Burstein HJ et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487-497. https://doi.org/10.1007/s10549-020-05644-z
(67) Pichi B; Mazzola F; Bonsembiante A; Petruzzi G; Zocchi J; Moretto S et al. Corona-steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management. Oral Oncol. 2020;105:104682. http://doi.org/10.1016/j.oraloncology.2020.104682
(68) Denys A; Guiu B; Chevallier P; Digklia A; Kerviler E; Baere T. Interventional oncology at the time of COVID-19 pandemic: Problems and solutions. Diagn Interv Imaging. 2020;101(6):347-353. http://doi.org/10.1016/j.diii.2020.04.005
(69) Indini A; Aschele C; Cavanna L; Clerico M; Daniele B; Fiorentini G et al. Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey. Eur J Cancer. 2020;132:17-23. https://doi.org/10.1016/j.ejca.2020.03.024
(70) Shuman AG; Pentz RD. Cancer Research Ethics and COVID-19. Oncologist. 2020;25(6):458-459. http://doi.org/10.1634/theoncologist.2020-0221
(71) National University Cancer Institute of Singapore (NCIS) Workflow Team. A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore. Ann Oncol. 2020;31(7):840-843. http://doi.org/10.1016/j.annonc.2020.03.306
(72) Lambertini M; Toss A; Passaro A; Criscitiello C; Cremolini C; Cardone C et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: Young oncologists’ perspective. ESMO Open. 2020;5(2):e000759. http://doi.org/10.1136/esmoopen-2020-000759
(73) Lyon D. COVID-19, Cancer and financial toxicity. Oncol Nurs Forum. 2020;47(3):253-254. http://doi.org/10.1188/20.ONF.253-254
(74) Bonomi L; Ghilardi L; Arnoldi E; Tondini CA; Bettini AC. A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in a patient with advanced lung cancer patient with a long-time response to nivolumab. J Thorac Oncol. 2020;15(6):e83-85. https://doi.org/10.1016/j.jtho.2020.03.021
(75) The Lancet Oncology. COVID-19: Global consequences for oncology. Lancet Oncol. 2020;21(4):467. https://doi.org/10.1016/S1470-2045(20)30175-3
(76) Zaorsky NG; Yu JB; McBride SM; Dess RT; Jackson WC; Mahal BA et al. Prostate cancer radiation therapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020;5(4):659-665. http://doi.org/10.1016/j.adro.2020.03.010
(77) Bartlett DL; Howe JR; Chang G; Crago A; Hogg M; Karakousis G et al. Management of cancer surgery cases during the COVID-19 pandemic: Considerations. Ann Surg Oncol. 2020;27(6):1717-1720. http://doi.org/10.1245/s10434-020-08461-2
(78) Kutikov A; Weinberg DS; Edelman MJ; Horwitz EM; Uzzo RG; Fisher RI. A war on two fronts: Cancer care in the time of COVID-19. Ann Intern Med. 2020;172(11):756-758. http://doi.org/10.7326/M20-1133
(79) Salako O; Okunade K; Allsop M; Habeebu M; Toye M; Oluyede G et al. Upheaval in cancer care during the COVID-19 outbreak. ecancer. 2020;14:ed97. http://doi.org/10.3332/ecancer.2020.ed97
How to Cite
VANCOUVER
ACM
ACS
APA
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Download Citation
License
Copyright (c) 2020 Avances en Enfermería
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published by Avances en Enfermería are licensed under the Creative Commons Attribution 4.0 International License. Starting 2020, we added the CC-BY-NC recognition to the license, which means anyone is allowed to copy, redistribute, remix, transmit and transform our contents with non-commercial purposes, and although new works must adequately cite the original work and source and also pursue non-commercial purposes, users do not have to license derivative works under the same terms.
